Hydroxychloroquine fails as postexposure prophylaxis for COVID-19
However, the trial did have limitations, researchers note
Read More
Tag: prophylaxis
Use of Roche’s haemophilia A therapy Hemlibra expanded in the US
Roche’s Hemlibra has been approved in the US for routine prophylaxis of bleeding episodes patients with haemophilia A without factor VIII inhibitors.
Read More
Setback for Pharming’s bid to expand use of Ruconest
US regulators have turned down Pharming’s application to expand the approved uses of Ruconest to include prophylaxis in patients with hereditary angioedema (HAE).
Read More
Kymab’s antibody shows early promise in GvHD prophylaxis
UK group Kymab has unveiled what it says are “remarkable” early stage results for its new antibody therapy KY1005 in animal models of acute graft-versus-host-disease (GvHD).
Read More
EU clear’s Gilead’s Truvada for HIV PrEP
European regulators have issued a green light for the use of Gilead’s Truvada to cut the risk of HIV infection in adults.
Read More
- NHS reduces long waits for cancer care and achieves faster ambulance responses
- MHRA’s AI Airlock to address challenges for regulating AI medical devices
- Oregon and Lantern collaborate to develop drug candidate for various cancer indications
- OneChain’s CAR T trial treats its first cortical T-cell ALL patient
- Johns Hopkins scientists depict molecular pathway to track replication in cancer cells
